Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Diantha Duvall | F | 52 | 2 years | |
| John Hohneker | M | 64 | 3 years | |
| Kenneth J. Martin | M | 70 | 11 years | |
| Reinhard von Roemeling | M | - | 5 years | |
| Dora Ferrari | F | - | 3 years | |
| Kimberly Steinmann | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Perez | M | 59 | 12 years | |
| Michael Bonney | M | 65 | 20 years | |
| Ali Fattaey | M | 59 | 5 years | |
| James McNab | M | 80 | 17 years | |
| Michael Tomsicek | M | 58 | 5 years | |
| David McGirr | M | 69 | 12 years | |
| Thomas DesRosier | M | 69 | 2 years | |
| Nancy Hutson | M | 74 | 7 years | |
| David Tuck | M | 72 | 3 years | |
| Brian Piekos | M | 49 | 5 years | |
| Kenneth J. Pienta | M | 64 | 4 years | |
| Arthur Tzianabos | M | 60 |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 3 years |
| J. Singleton | M | 71 | 11 years | |
| Patrick Volkert Vink | M | 60 | 3 years | |
| Alison Lawton | F | 62 | 2 years | |
| Lori Kunkel | M | 66 | 6 years | |
| Theresa McNeely | F | 60 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 3 years |
| Mani Mohindru | M | 52 | 4 years | |
| Jane Ellen Henney | M | 76 | 2 years | |
| Michael B. Wood | M | 78 | 9 years | |
| Mark Corrigan | M | 66 | 7 years | |
| Lonnie Moulder | M | 66 | 5 years | |
| Martin Rosenberg | M | 78 | 9 years | |
| John P. Howe | M | 81 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 3 years |
| Timothy Keutzer | M | 56 | 1 years | |
| Rebecca J. Peterson | F | - |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 1 years |
| Matthew P. Kowalsky | M | 52 | 2 years | |
| Toni Spinazzola | F | - |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 1 years |
| Taylor Sandison | M | 52 | 1 years | |
| Orlando Oliveira | M | - | 1 years | |
| Gabriel Cohn | M | 65 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 2 years |
| Larry G. Edwards | M | 52 | 1 years | |
| Francesco Maria Lavino | M | 51 | 2 years | |
| Jerald Korn | M | 45 | 2 years | |
| Christine Guertin | F | - | 4 years | |
| Bumpus Durso | F | 54 | 6 years | |
| Frank Waligora | M | - | 8 years | |
| Paula Rusu | F | - | 4 years | |
| René Russo | M | 49 | 12 years | |
| John Mustillo | M | - | - | |
| Carrie Bourdow | F | 61 | 2 years | |
| Louis Villalba | M | 55 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 3 years |
| Thomas E. Rollins | M | - | 1 years | |
| Steven Gilman | M | 71 | 7 years | |
| Praveen Tipirneni | M | 55 | 13 years | |
| Gregory Stea | M | 66 | 13 years | |
| David Harding | M | 58 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 1 years |
| Lee M. Techner | M | - | 2 years | |
| Lorianne K. Masuoka | M | 62 | 2 years | |
| Mary Thistle | F | 64 | 6 years | |
| Charles Laranjeira | M | 58 | 4 years | |
| John D. Eisel | M | 47 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 1 years |
| Amy Reilly | F | 51 | 4 years | |
| Paul W. D. Chapman | M | - |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | - |
| Joseph Farmer | M | 52 | 3 years | |
| Thomas J. Ouellette | M | - | 1 years | |
| Sunil Patel | M | - | - | |
| Felix Geissler | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 64 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- William Steinkrauss
- Personal Network
